249 related articles for article (PubMed ID: 24627312)
1. An unusual class of anthracyclines potentiate Gram-positive antibiotics in intrinsically resistant Gram-negative bacteria.
Cox G; Koteva K; Wright GD
J Antimicrob Chemother; 2014 Jul; 69(7):1844-55. PubMed ID: 24627312
[TBL] [Abstract][Full Text] [Related]
2. Repurposing azithromycin and rifampicin against Gram-negative pathogens by combination with peptide potentiators.
Baker KR; Jana B; Hansen AM; Vissing KJ; Nielsen HM; Franzyk H; Guardabassi L
Int J Antimicrob Agents; 2019 Jun; 53(6):868-872. PubMed ID: 30447380
[TBL] [Abstract][Full Text] [Related]
3. Genetic and Chemical Screening Reveals Targets and Compounds to Potentiate Gram-Positive Antibiotics against Gram-Negative Bacteria.
Klobucar K; Jardine E; Farha MA; MacKinnon MR; Fragis M; Nkonge B; Bhando T; Borrillo L; Tsai CN; Johnson JW; Coombes BK; Magolan J; Brown ED
ACS Infect Dis; 2022 Oct; 8(10):2187-2197. PubMed ID: 36098580
[TBL] [Abstract][Full Text] [Related]
4. The Properties of Linezolid, Rifampicin, and Vancomycin, as Well as the Mechanism of Action of Pentamidine, Determine Their Synergy against Gram-Negative Bacteria.
Tang M; Zhao D; Liu S; Zhang X; Yao Z; Chen H; Zhou C; Zhou T; Xu C
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762115
[TBL] [Abstract][Full Text] [Related]
5. Screening, isolation, taxonomy and fermentation of an antibiotic producer Streptomyces xinghaiensis from soil capable of acting against linezolid resistant strains.
Kumar KS; Anuradha S; Sarma GR; Venkateshwarlu Y; Kishan V
Indian J Exp Biol; 2012 Oct; 50(10):718-28. PubMed ID: 23214266
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of Antibiotic Activity by a Novel Cationic Peptide: Potency and Spectrum of Activity of SPR741.
Corbett D; Wise A; Langley T; Skinner K; Trimby E; Birchall S; Dorali A; Sandiford S; Williams J; Warn P; Vaara M; Lister T
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533232
[TBL] [Abstract][Full Text] [Related]
7. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
8. The polymyxin derivative NAB739 is synergistic with several antibiotics against polymyxin-resistant strains of Escherichia coli, Klebsiella pneumoniae and Acinetobacter baumannii.
Tyrrell JM; Aboklaish AF; Walsh TR; Vaara T; Vaara M
Peptides; 2019 Feb; 112():149-153. PubMed ID: 30586602
[TBL] [Abstract][Full Text] [Related]
9. Colistin and anti-Gram-positive bacterial agents against Acinetobacter baumannii.
Liu B; Liu Y; Di X; Zhang X; Wang R; Bai Y; Wang J
Rev Soc Bras Med Trop; 2014 Jul; 47(4):451-6. PubMed ID: 25229285
[TBL] [Abstract][Full Text] [Related]
10. Mutactimycin E, a new anthracycline antibiotic with gram-positive activity.
Hopp DC; Rabenstein J; Rhea J; Smith C; Romari K; Clarke M; Francis L; Irigoyen M; Milanowski D; Luche M; Carr GJ; Mocek U
J Antibiot (Tokyo); 2008 Nov; 61(11):675-9. PubMed ID: 19168982
[TBL] [Abstract][Full Text] [Related]
11. Resomycins A to approximately C: new anthracyclinone antibiotics formed by a terrestrial Streptomyces sp.
Maskey RP; Grün-Wollny I; Laatsch H
J Antibiot (Tokyo); 2003 Sep; 56(9):795-800. PubMed ID: 14632291
[No Abstract] [Full Text] [Related]
12. Synergism between Rifampicin and Cationic Polyurethanes Overcomes Intrinsic Resistance of
Tantisuwanno C; Dang F; Bender K; Spencer JD; Jennings ME; Barton HA; Joy A
Biomacromolecules; 2021 Jul; 22(7):2910-2920. PubMed ID: 34085824
[TBL] [Abstract][Full Text] [Related]
13. Lysine-Based Small Molecule Sensitizes Rifampicin and Tetracycline against Multidrug-Resistant
Konai MM; Haldar J
ACS Infect Dis; 2020 Jan; 6(1):91-99. PubMed ID: 31646866
[TBL] [Abstract][Full Text] [Related]
14. Genomic analysis of in vivo acquired resistance to colistin and rifampicin in Acinetobacter baumannii.
Jaidane N; Naas T; Mansour W; Radhia BB; Jerbi S; Boujaafar N; Bouallegue O; Bonnin RA
Int J Antimicrob Agents; 2018 Feb; 51(2):266-269. PubMed ID: 29127051
[TBL] [Abstract][Full Text] [Related]
15. Aranciamycins I and J, Antimycobacterial Anthracyclines from an Australian Marine-Derived Streptomyces sp.
Khalil ZG; Raju R; Piggott AM; Salim AA; Blumenthal A; Capon RJ
J Nat Prod; 2015 Apr; 78(4):949-52. PubMed ID: 25789410
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of daptomycin, linezolid and rifampicin on Staphylococcus epidermidis biofilms.
Leite B; Gomes F; Teixeira P; Souza C; Pizzolitto E; Oliveira R
Curr Microbiol; 2011 Sep; 63(3):313-7. PubMed ID: 21761219
[TBL] [Abstract][Full Text] [Related]
17. Identification of Streptomyces sp. KH29, which produces an antibiotic substance processing an inhibitory activity against multidrug-resistant Acinetobacter baumannii.
Lee KH; Kim KW; Rhee KH
J Microbiol Biotechnol; 2010 Dec; 20(12):1672-6. PubMed ID: 21193822
[TBL] [Abstract][Full Text] [Related]
18. Sugar-Grafted Cyclodextrin Nanocarrier as a "Trojan Horse" for Potentiating Antibiotic Activity.
Li M; Neoh KG; Xu L; Yuan L; Leong DT; Kang ET; Chua KL; Hsu LY
Pharm Res; 2016 May; 33(5):1161-74. PubMed ID: 26792570
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of ciprofloxacin or linezolid in combination with rifampicin against Enterococcus faecalis in biofilms.
Holmberg A; Mörgelin M; Rasmussen M
J Antimicrob Chemother; 2012 Feb; 67(2):433-9. PubMed ID: 22110086
[TBL] [Abstract][Full Text] [Related]
20. Repurposing Azithromycin and Rifampicin Against Gram-Negative Pathogens by Combination With Peptidomimetics.
Baker KR; Jana B; Hansen AM; Nielsen HM; Franzyk H; Guardabassi L
Front Cell Infect Microbiol; 2019; 9():236. PubMed ID: 31334131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
